| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.5M | -79.7% |
| Cost of Revenue | $1.3M | -95.0% |
| R&D Expense | $197.6M | +37.6% |
| SG&A Expense | $55.1M | -2.2% |
| Operating Income | -$143.2M | -146.1% |
| Interest Expense | $11.7M | +56.6% |
| Pre-tax Income | -$128.3M | -138.5% |
| Income Tax | -$1.5M | -145.7% |
| Net Income | -$126.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $228.0M | -59.0% |
| Inventory | $6.9M | — |
| Current Assets | $476.8M | -24.1% |
| Total Assets | $705.0M | -12.9% |
| Current Liabilities | $75.9M | +106.5% |
| Long-term Debt | $144.5M | +6.6% |
| Total Liabilities | $229.0M | +7.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.1M | -150.4% |
| Capital Expenditures | $17.7M | +1.4% |
| Investing Cash Flow | -$182.7M | -171.2% |
| Financing Cash Flow | $1.4M | -98.5% |
| Free Cash Flow | -$162.7M | -160.2% |
| -138.5% |
| EPS (Basic) | -$2.71 | -137.8% |
| EPS (Diluted) | -$2.71 | -138.5% |
| Stockholders' Equity |
| $476.0M |
| -20.1% |